Skip to main content

Basel Area sets new record for new company settlements

| News

Basel Area sets new record for new company settlements


For Basel Area Business & Innovation, 2021 was a record year. Last year, the investment and innovation promotion agency supported the settlement of 39 new businesses and creation of 76 startups in the two Basel cantons and Jura.

The Switzerland Innovation Park Basel Area moves to the neighboring tower at the Novartis Campus (img: Biondopictures)

The support of Basel Area Business & Innovation helped 39 new companies establish themselves in the Basel Area. This exceeds the previous year’s figure of 27 company settlements. As the investment and innovation promotion agency for the cantons of Basel-Landschaft, Basel-Stadt and Jura reported, by far the largest share was attributable to the life sciences sector, with 28 new companies. Seven of them operate in the field of digital health. Five new companies in the region work in production and process technology.

The 39 new companies come from 15 countries. Five are from France and five from the USA, three from the United Kingdom and nine from Swiss cantons outside the Basel Area.

Foundation of 76 startups supported

The agency also supported the foundation of 76 startups in the Basel Area in 2021. While this is six fewer than in the previous year, it is the second highest figure ever achieved. The appeal of the Basel Area for new company settlements was enhanced through venture accelerators and incubators launched by the location promotion such as BaseLaunch (biotech), DayOne (digital health), i4Challenge (industrial transformation) and Venture Monitoring, a mentoring for startups service.

The Switzerland Innovation Park Basel Area also saw “pleasing” growth. There are now 68 companies and 14 research groups at its sites in Allschwil in the canton of Basel-Landschaft, Basel, Jura and the Novartis Campus. To make space for the growth of the Innovation Park at the Novartis Campus, this will move to a much bigger neighboring building on 1 April.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

Paradigm shift in pain management

Pain is a crucial sensation for survival, but it can also drive us to depression and long-term suffering if not...
Read More

BOOM Summit in Basel accelerates health technology

The BOOM Summit at Messe Basel in April 2024 will be a completely new kind of healthcare conference. The first...
Read More

Investors stump up 3.7 million Swiss francs in Onena Medicines

Onena Medicines has secured an investment of 3.7 million Swiss francs. The portfolio company of the biotech startup incubator BaseLaunch...
Read More

Do you have a question? We'd like to hear from you.